These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15562371)

  • 1. Highlights from the 13th International Symposium on HIV and Emerging Infectious Diseases (ISHEID).
    Lafeuillade A; Solas C; Hittinger G; Rieu A; Tamalet C
    HIV Clin Trials; 2004; 5(5):305-22. PubMed ID: 15562371
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral presentation abstracts from the 13th International Symposium on HIV and Emerging Infectious Diseases (ISHEID). June 3-5, 2004. Toulon, France.
    HIV Clin Trials; 2004; 5(5):323-56. PubMed ID: 15562372
    [No Abstract]   [Full Text] [Related]  

  • 3. Statements from the 15th International Symposium on HIV and Emerging Infectious Diseases (ISHEID), Toulon, France, May 28-30, 2008.
    Haubrich R; Soriano V; Lafeuillade A
    HIV Clin Trials; 2008; 9(5):348-65. PubMed ID: 18977724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highlights from the 2012 International Symposium on HIV & Emerging Infectious Diseases (ISHEID): from cART management to the search of an HIV cure.
    Lafeuillade A; Soriano V; Suzan-Monti M; Stevenson M; Izopet J; Stellbrink HJ
    AIDS Res Ther; 2012 Aug; 9(1):23. PubMed ID: 22853692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highlights from the 2014 International Symposium on HIV & Emerging Infectious Diseases (ISHEID): from cART management to the end of the HIV pandemic.
    Lafeuillade A; Wainberg M; Gougeon ML; Loes SK; Halfon P; Tissot-Dupont H
    AIDS Res Ther; 2014; 11():28. PubMed ID: 25165483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abstracts of the 17th International Symposium on HIV and Emerging Infectious Diseases (ISHEID). Marseille, France. May 23-25, 2012.
    Rockstroh J
    Retrovirology; 2012 May; 9 Suppl 1(Suppl 1):I1-24, O1-11, P1-151. PubMed ID: 22676907
    [No Abstract]   [Full Text] [Related]  

  • 7. Highlights from the 20th International Symposium on HIV and Emerging Infectious Diseases (ISHEID) 16-18 May 2018, Marseille, France: from HIV and comorbidities to global health.
    Psomas C; Kinloch S; Sabin C; Soriano V; Solas C; Orkin C; Bernardino J; Curran A; Routy JP; Enel P; Philibert P; Lafeuillade A
    J Virus Erad; 2018 Jul; 4(3):196-207. PubMed ID: 30050686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highlights from the 2016 International Symposium on HIV & Emerging Infectious Diseases (ISHEID): 25-27 May, Marseille, France.
    Routy JP; Psomas C; Soriano V; Philibert P; Tissot-Dupont H; Lafeuillade A
    J Virus Erad; 2016 Jul; 2(3):187-92. PubMed ID: 27482461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Speaker presentations of the 2018 International Symposium on HIV and Emerging Infectious Diseases (ISHEID).
    J Virus Erad; 2018 May; 4(Suppl 1):1-37. PubMed ID: 30079251
    [No Abstract]   [Full Text] [Related]  

  • 10. [Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy].
    Medrano J; Soriano V
    Med Clin (Barc); 2009 Apr; 132(13):505-6. PubMed ID: 19359003
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiretroviral therapy for naïve and for treatment-experienced HIV patients, and prevention of HIV transmission.
    Antunes F
    Curr Opin HIV AIDS; 2011 Dec; 6 Suppl 1():S1-2. PubMed ID: 22156774
    [No Abstract]   [Full Text] [Related]  

  • 12. HIV-2 down, HIV-1 to go? Understanding the possibilities of treatment as prevention.
    Bruhn CA; Gilbert MT
    Lancet Infect Dis; 2011 Apr; 11(4):260-1. PubMed ID: 21453865
    [No Abstract]   [Full Text] [Related]  

  • 13. Highlights on HIV eradication in 2013.
    Monforte Ad; Svicher V; Nozza S; Lazzarin A; Marchetti G; Perno CF
    AIDS; 2014 Jan; 28(1):1-7. PubMed ID: 23939240
    [No Abstract]   [Full Text] [Related]  

  • 14. Primary HIV Infection, phylogenetics, and antiretroviral prevention.
    Pillay D; Fisher M
    J Infect Dis; 2007 Apr; 195(7):924-6. PubMed ID: 17330780
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention of occupational human immunodeficiency virus transmission in surgeons in the era of highly active antiretroviral therapy.
    Puro V; De Carli G; ;
    Arch Surg; 2006 Jun; 141(6):611; author reply 612. PubMed ID: 16785366
    [No Abstract]   [Full Text] [Related]  

  • 16. Can antiretroviral therapy be used to prevent sexual transmission of human immunodeficiency virus type 1?
    Hosseinipour M; Cohen MS; Vernazza PL; Kashuba AD
    Clin Infect Dis; 2002 May; 34(10):1391-5. PubMed ID: 11981736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A saga in international HIV policy modeling: preventing mother-to-child HIV transmission.
    Kahn JG; Marseille E
    J Policy Anal Manage; 2002; 21(3):499-505. PubMed ID: 12725210
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful prevention of HIV mother-to-child transmission with dolutegravir-based combination antiretroviral therapy in a vertically infected pregnant woman with multiclass highly drug-resistant HIV-1.
    Pinnetti C; Tintoni M; Ammassari A; Tamburrini E; Bernardi S; Liuzzi G; Scambia G; Perno CF; Floridia M; Antinori A; Cavaliere AF
    AIDS; 2015 Nov; 29(18):2534-7. PubMed ID: 26372490
    [No Abstract]   [Full Text] [Related]  

  • 19. HIV infection.
    Talbot M
    Clin Evid; 2006 Jun; (15):937-54. PubMed ID: 16973039
    [No Abstract]   [Full Text] [Related]  

  • 20. CROI covers advancements from start to finish. Highlights of recent HIV meeting run gamut from basic science to HIV prevention and vaccine research.
    Kresge KJ
    IAVI Rep; 2006; 10(1):9-12, 16. PubMed ID: 16625719
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.